PIMREG and prostate carcinoma: Recent studies have found that the upregulation of PIMREG expression is related to the poor prognosis of breast cancer, neuroblastoma, cholangiocarcinoma, osteosarcoma, glioma, prostate cancer and other cancers (9–14).